Charles Schwab director granted 1,317 stock options at $101.57
Charles Schwab Corporation director reports new stock option grant.
Rhea-AI Filing Summary
Charles Schwab Corporation director reports new stock option grant. A company director filed a Form 4 disclosing receipt of a nonqualified stock option to buy 1,317 shares of Schwab common stock on 01/02/2026 at an exercise price of $101.57 per share. The option was granted under the Directors' Deferred Compensation Plan II, vested immediately on the grant date, and is scheduled to expire on 01/02/2036. The filing states the option was received in lieu of cash compensation otherwise payable as director fees and is held as a direct ownership position.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Nonqualified Stock Option (right to buy) | 1,317 | $0.00 | $0.00 |
Footnotes (2)
- F1. The option was received pursuant to the Directors' Deferred Compensation Plan II and vested immediately.
- F2. The option was received in lieu of cash compensation otherwise payable as director fees.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SCHW disclose in this Form 4 filing?
What is the exercise price of the new Charles Schwab (SCHW) stock options?
When do the reported SCHW director stock options vest and expire?
Why did the Charles Schwab director receive these stock options instead of cash?
How many derivative securities does the SCHW director beneficially own after this transaction?
What type of security underlies the reported Charles Schwab stock option grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.